je.st
news
MSD Animal Health Receives Positive Opinion from European Medicines Agency for BRAVECTO (fluralaner)
2013-12-17 10:00:00| Merck.com - Corporate News
Dateline City: SUMMIT, N.J. New Chewable Tablet Treatment for Fleas and Ticks in Dogs Effective For 12 Weeks (8 weeks for Rhipicephalus sanguineus ticks) SUMMIT, N.J.--(BUSINESS WIRE)--MSD Animal Health (known as Merck Animal Health in the United States and Canada) today announced that the Committee for Medicinal Products for Veterinary Use (CVMP) of the European Medicines Agency has adopted a positive opinion, recommending the granting of a marketing authorization for the veterinary medicinal product BRAVECTO (fluralaner) chewable tablets for dogs (112.5 mg, 250 mg, 500 mg, 1000 mg, 1400 mg). Language: English Contact: MSD Animal HealthAmy Firsching, +1 908 473 6357amy.firsching@merck.comorPam Eisele, +1 908 423 5042pamela_eisele@merck.com Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: health
positive
opinion
agency
Category:Biotechnology and Pharmaceuticals